Peristomal Pyoderma Gangrenosum Responding to Risankizumab

Overview of attention for article published in Advances in skin & wound care (Print), June 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 public wall post.

Evidence to support available therapies for pyoderma gangrenosum (PG) is limited. Many patients do not respond to topical…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.